Product Information

FEBUXOSTAT 40 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1875 per EA under NDC 00904739546. Its NADAC has been published 147 times since Jan 24, 2024.

FDA first approved this application on Dec 30, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Febuxostat market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FEBUXOSTAT 40 MG TABLET

Febuxostat
$0.1875per EA
High Outlier

Strength

40 mg/1

NDC

00904739546

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

FEBUXOSTAT

Approval Type

Generic (ANDA)

FDA Application

ANDA210461

FDA Approved

12/30/2019

TE Code

AB

On Market Since

12/30/2019

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for FEBUXOSTAT 40 MG TABLET has been published 147 times since Jan 24, 2024, and over the history we have for it it has declined 53.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1875 per EA
All-time high$0.5086 (Apr 10, 2024)
All-time low$0.1875 (Oct 21, 2026)
52-week high$0.2285
52-week low$0.1875
Median price$0.3238
Average price$0.3040
Largest weekly change-29.6% (Apr 17, 2024)
Weeks tracked147
Tracking sinceJan 24, 2024

Price History

1W

0.0%

1M

-1.9%

3M

-11.4%

6M

-11.4%

1Y

-23.9%

3Y

N/A

5Y

N/A

All

-53.6%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FEBUXOSTAT 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 40 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1875 per EA (NDC 00904739546), effective Nov 11, 2026.

How has the price of FEBUXOSTAT 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for FEBUXOSTAT 40 MG TABLET has declined 53.6%. It has been tracked across 147 weekly CMS publications since Jan 24, 2024.

What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 40 MG TABLET?

Since Jan 24, 2024, the NADAC for FEBUXOSTAT 40 MG TABLET has ranged from a low of $0.1875 (Oct 21, 2026) to a high of $0.5086 (Apr 10, 2024), with a median of $0.3238 per EA.

Are there cheaper alternatives to FEBUXOSTAT 40 MG TABLET?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FEBUXOSTAT 40 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FEBUXOSTAT 40 MG TABLET?

FEBUXOSTAT 40 MG TABLET (NDC 00904739546) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.